1. Neoadjuvant chemotherapy with ifosfamide and cisplatin combination in advanced head and neck cancer

   • V. R. Pai
   • A. T. Mazumdar
   • K. A. Pathak

   Original Article Pages: 1 - 5

2. Phase I dose escalation study of docetaxel with filgrastim support in patients with advanced solid tumors

   • Gregory A. Masters
   • Bruce E. Brockstein
   • Mark J. Ratain

   Original Article Pages: 7 - 12

3. Nasal NK/T-cell lymphoma with disseminated disease treated with aggressive combined therapy

   • Agustin Avilés
   • Natividad Neri
   • M. Jesús Nambo

   Original Article Pages: 13 - 17

4. Docetaxel and vinorelbine

   • Mario Airoldi
   • Giorgio Cortesina
   • Pietro Gabriele

   Original Article Pages: 19 - 24

5. Liver metastasis at the time of initial diagnosis of lung cancer

   • Katsunori Kagohashi
   • Hiroaki Satoh
   • Kiyohisa Sekizawa

   Original Article Pages: 25 - 28

6. Inhibition of PC-3 prostate cancer cell growth in vitro using both antisense oligonucleotides and taxol

   • Marvin Rubenstein
   • Leonid Slobodskoy
   • Patrick Guinan

   Original Article Pages: 29 - 35

7. Phase II study of weekly irinotecan (CPT-11) as second-line treatment of patients with advanced colorectal cancer

   • J. Cassinello
   • P. López-Alvarez
   • J. Dorta

   Original Article Pages: 37 - 43

8. Serum markers variation consistent with autoschizis induced by ascrobic acid-menadione in patients with prostate cancer

   • Eduardo Lasalvia-Prisco
   • Silvia Cucchi
   • William Gordon

   Original Article Pages: 45 - 52

9. Phase I trial of fludarabine and paclitaxel in non-hodgkin’s lymphoma

   • Muhammad R. Abbasi
   • Joseph A. Sparano
   • Peter H. Wiernik

   Original Article Pages: 53 - 58

10. Expression of somatostatin receptor subtypes 1 to 5 in tumor tissue and intratumoral vessels in malignant endocrine pancreatic tumors

    • Marie-Louise Fjällskog
    • Eva Ludvigsen
    • Eva T. Janson

    Original Article Pages: 59 - 67

11. Treatment of chronic myeloid leukemia with autologous transplantation using peripheral blood stem cells or bone marrow cultured in IL-2 followed by IL-2, GM-CSF, and IFN-α administration

    • Roman Hájek
    • Daniela Zácková
    • Jirí Vorlícek

    Original Article Pages: 69 - 76

12. Quantitation of cyclin D1 over-expression using competitive fluorescent reverse transcription polymerase chain reaction

    • C. L. Wickham
    • H. Armitage
    • S. Ellard

    Original Article Pages: 77 - 85

13. Long-term survival of patients given hormonal therapy for metastatic endometrial stromal sarcoma

    • J. -P. Spano
    • J. C. Soria
    • J. -L Breau

    Case Report Pages: 87 - 93